Shanna Dewaele

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Basal Cell Carcinoma

Hyaluronic Acid

Top Venues

Nucleic acid therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shanna Dewaele, Louis Delhaye, Boel De Paepe, Bram Bogaert, Ramiro Martinez, Jasper Anckaert, Nurten Yigit, Justine Nuytens, Rudy Van Coster, Sven Eyckerman, Koen Raemdonck, Pieter Mestdagh
Mammalian Target of Rapamycin Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells. Nucleic acid therapeutics (2023)
Shanna Dewaele, Louis Delhaye, Boel De Paepe, Eric James de Bony, Jilke De Wilde, Katrien Vanderheyden, Jasper Anckaert, Nurten Yigit, Justine Nuytens, Eveline Vanden Eynde, Joél Smet, Maxime Verschoore, Fariba Nemati, Didier Decaudin, Manuel J Rodrigues, Peihua Zhao, Aart G Jochemsen, Eleonora Leucci, Jo Vandesompele, Jo Van Dorpe, Jean-Christophe Marine, Rudy Van Coster, Sven Eyckerman, Pieter Mestdagh
Correction to: The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival. Oncogene (2021)
Shanna Dewaele, Louis Delhaye, Boel De Paepe, Eric James de Bony, Jilke De Wilde, Katrien Vanderheyden, Jasper Anckaert, Nurten Yigit, Justine Nuytens, Eveline Vanden Eynde, Joél Smet, Maxime Verschoore, Fariba Nemati, Didier Decaudin, Manuel J Rodrigues, Peihua Zhao, Aart G Jochemsen, Eleonora Leucci, Jo Vandesompele, Jo Van Dorpe, Jean-Christophe Marine, Rudy Van Coster, Sven Eyckerman, Pieter Mestdagh
The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival. Oncogene (2021)